PharmaStem Therapeutics, Inc.

The company is focused on the preservation of cord and placental blood stem cells.

Biocyte Corporation, the predecessor of PharmaStem, was founded in 1985 and was the pioneer in the development and implementation of cord blood preservation and its therapeutic use.

The company is dedicated to promoting research and development of new therapies using umbilical cord and placental blood stem cells. Its technology is lisenced to several cord blood banks.

Nicholas Didier, CEO & President

69 Prospect Avenue
Larchmont, NY 10538
USA
Phone: +1-914-833-9227
Fax: +1-914-833-3175

The cryopreservation of blood directly after birth from the infant’s umbilical cord and placenta enables the haematopoietic (blood producing) stem cells present in the blood to be thawed and processed for further use.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.